GeDDiS
A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas.
GeDDiS was a randomised, phase III multinational trial, with patients stratified according to age (≤18 or >18) and histological subtype (uterine leiomyosarcoma, synovial sarcoma, pleomorphic sarcoma, [...]
Area:
Sarcoma
Phase:
Phase III
Status:
Closed